NCI Logo Extramural Funding Opportunities Site map

Contact us
Home | Funding | Advisory | NCI Research Priorities | Funded Awards | Research Resources | Events | NCI News

advanced search  

NCI FUNDING POLICY UNDER THE REGULAR APPROPRIATION FOR
FY 2009 RESEARCH PROJECT GRANT (RPG) AWARDS
 

Quick Links
RELATED LINKS: Page 1
  NCI RESOURCES
Grant Funding Resources
Grant Review Process
Resources by Category
redline1.gif - 950 Bytes
  NIH RESOURCES
Guide for Grants & Contracts
Office of Extramural Research
redline1.gif - 950 Bytes
  OTHER LINKS
CancerTrials Update!
Surveillance, Epidemiologist
and End Results (SEER)
redline1.gif - 950 Bytes
  OTHER CONTACTS
Program Director's Roster
E-mail: NCI Referral Officer







  • Non-competing Continuations (Type 5s) - all RPG mechanisms
  • Consistent with the NIH policy, NOT-OD-09-066, which was published in the NIH Guide to Grants and Contracts on March 18, 2009, NCI will issue non-competing awards to research project grant mechanisms at their 2009 committed level. Non-competing awards previously issued in FY 2009 at reduced levels will be revised to restore funds to the committed level.

  • Competing Budget Policy Statement
  • Consistent with the FY 2009 appropriation, the FY 2009 average cost of competing grants is allowed to increase by 3 percent over the FY 2008 competing average cost. The NCI will give funding priority to new and early stage investigators.

  • Competing New (Type 1) and Continuation (Type 2) Traditional R01s
  • Effective with the September 2008 National Cancer Advisory Board (NCAB) round (the first funding cycle of FY 2009), Type-1 and Type-2 R01 applications up to the 16.0 percentile will be paid. Non-percentiled R01s will be paid on a case by case basis.

  • New Exploratory Development (Type 1) R21 up to the 16.0 percentile will be paid.
  • New Small grants (Type 1) R03s up to priority score 210 will be paid.
  • New AREA (Type 1) R15s up to priority score 175 will be paid.
  • Program Project (P01) Applications (new and competing continuations)

    P01s will continue to be paid on a case by case basis. P01 applicants will be notified of their potential for funding by the NCI program staff.

  • Large Dollar Amount Percentiled R01s
  • For the first and second funding cycles of FY 2009, the pay line for large percentiled R01 applications ($700,000 or more direct cost requested in any year) was the 12.0 percentile – consistent with the policy under the continuing resolution. The payline for the full year has not yet been established.

  • Competing R01 Applications from First-time R01 Investigators
  • NCI has a strong commitment to first-time R01 awardees. Therefore, applicants eligible for consideration as first-time R01 investigators under the FY 2009 appropriation will be paid using an extended payline of the 22.0 percentile. The current definition of first-time R01 investigators can be found in the Application for a Public Health Service Grants (PHS-398): http://grants.nih.gov/grants/funding/phs398/phs398.pdf (PDF) - scroll to page I-25.

  • Request for Applications (RFAs)
  • NCI is committed to the review of RFAs that have been previously announced and solicited for competition in FY 2009. As always, success rates for RFAs will depend on the amount of funds available, the number of applications submitted, programmatic priority and the scientific merit of the applications received. Please consult the program director listed on your summary statement if you have questions.

  • Amended Applications (all mechanisms)
  • Amended applications submitted for the February/March, 2009 receipt date, will be considered for funding under FY 2010 budget plans, which are not yet known and may be different from these FY 2009 announced levels.

  • Policy Reductions (all mechanisms)
  • During FY 2009 the competing renewals will be funded at an average 3 percent increase over the current level and the new grants at 83 percent of the IRG recommended level. Competing awards previously issued in FY 2009 under the continuing resolution policy reductions will be revised to restore funds to these policy levels unless the award was made as an exception to standard policy.


National Cancer InstituteNational Cancer Institute (NCI) National Institutes of HealthNational Institutes of Health (NIH)Health & Human ServicesDepartment of Health & Human Services (DHHS)USA.gov National Institutes of HealthNational Institutes of Health (NIH) Health & Human ServicesDepartment of Health & Human Services (DHHS) First Gov
Related
Links

Privacy
Statement